NOVOEIGHT

Product NDC
0169-7850
Requested package NDC
0169-7850-01
11-digit product format
001697850
Labeler code
0169
Product ID
0169-7850_590d35a4-6e12-450e-9508-0c5bbf2ac427
Type
PLASMA DERIVATIVE
Nonproprietary name
antihemophilic factor recombinant
Dosage form
KIT
Labeler
Novo Nordisk
Application
BLA125466
Marketing category
BLA
Marketing start
2015-04-01
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
NOVOEIGHT
Listing expiration
2026-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1719246Internal RxNorm lookup
1737559Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0a19a631-f494-48ac-8cab-7d572bf7b03dAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0169-7850-01NOVOEIGHT1 in 1 KITKIT112
0169-7851-11NOVOEIGHT4 mL in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,4 mL125 [iU] in 1mL12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0169-7850-01EA - Each0169-785080a7757c-49dd-4e9e-9e0c-c2c6d5006af912015-04-03

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0169-7850NOVOEIGHT (ANTIHEMOPHILIC FACTOR RECOMBINANT) KIT [NOVO NORDISK]12Current NDC, Legacy NDC, 2 package rows20240524_0a19a631-f494-48ac-8cab-7d572bf7b03d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NOVOEIGHTANTIHEMOPHILIC FACTOR RECOMBINANTNovo Nordisk0a19a631-f494-48ac-8cab-7d572bf7b03d2020-07-31Warnings, Adverse reactionsExact identifier
application number: BLA125466
ndc (package): 0169-7850-01
ndc (product): 0169-7850
ndc11 (package): 00169785001

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125466NovoeightAntihemophilic Factor (Recombinant)351(a)Rx2026-10-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1719246Novoeight 1 UNT InjectionPSN0a19a631-f494-48ac-8cab-7d572bf7b03d12
1737559turoctocog alfa 1 UNT InjectionPSN0a19a631-f494-48ac-8cab-7d572bf7b03d12
1719246turoctocog alfa 1 UNT Injection [Novoeight]SBD0a19a631-f494-48ac-8cab-7d572bf7b03d12
1737559turoctocog alfa 1 UNT InjectionSCD0a19a631-f494-48ac-8cab-7d572bf7b03d12
1737559antihemophilic factor, human B-domain truncated recombinant 1 UNT InjectionSY0a19a631-f494-48ac-8cab-7d572bf7b03d12
1719246Novoeight 1 UNT InjectionSY0a19a631-f494-48ac-8cab-7d572bf7b03d12

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0169-7850-01001697850011 KIT in 1 KIT (0169-7850-01) * 4 mL in 1 VIAL, GLASS (0169-7851-11) * 4 mL in 1 SYRINGE, GLASS (0169-7008-98) 1 kit2015-04-010000-00-00NoNoCurrent